Drug Shortage Report for RECOMBIVAX HB
Report ID | 52350 |
Drug Identification Number | 02245977 |
Brand name | RECOMBIVAX HB -(ADULT DIALYSIS-PRESERVATIVE FREE) |
Common or Proper name | (hepatitis B vaccine [recombinant]) |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
Strength(s) | 40MCG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1DOSE VIAL |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-06-18 |
Actual start date | 2018-06-18 |
Estimated end date | 2021-04-05 |
Actual end date | 2021-03-15 |
Shortage status | Resolved |
Updated date | 2021-03-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-06-13 | English | Compare |
v2 | 2018-06-13 | English | Compare |
v3 | 2018-06-13 | French | Compare |
v4 | 2018-06-14 | English | Compare |
v5 | 2018-06-14 | English | Compare |
v6 | 2018-06-18 | English | Compare |
v7 | 2018-06-18 | French | Compare |
v8 | 2018-06-19 | English | Compare |
v9 | 2018-08-30 | English | Compare |
v10 | 2018-10-15 | English | Compare |
v11 | 2018-10-15 | English | Compare |
v12 | 2018-10-15 | English | Compare |
v13 | 2018-12-11 | English | Compare |
v14 | 2019-07-04 | English | Compare |
v15 | 2019-07-04 | English | Compare |
v16 | 2019-07-04 | French | Compare |
v17 | 2019-09-09 | English | Compare |
v18 | 2019-09-09 | French | Compare |
v19 | 2021-02-03 | English | Compare |
v20 | 2021-03-15 | English | Compare |